title: Small-molecule inhibitors of toxT expression in Vibrio cholerae.
abstract: Vibrio cholerae, a Gram-negative bacterium, infects humans and causes cholera, a severe disease characterized by vomiting and diarrhea. These symptoms are primarily caused by cholera toxin (CT), whose production by V. cholerae is tightly regulated by the virulence cascade. In this study, we designed and carried out a high-throughput chemical genetic screen to identify inhibitors of the virulence cascade. We identified three compounds, which we named toxtazin A and toxtazin B and B', representing two novel classes of toxT transcription inhibitors. All three compounds reduce production of both CT and the toxin-coregulated pilus (TCP), an important colonization factor. We present evidence that toxtazin A works at the level of the toxT promoter and that toxtazins B and B' work at the level of the tcpP promoter. Treatment with toxtazin B results in a 100-fold reduction in colonization in an infant mouse model of infection, though toxtazin A did not reduce colonization at the concentrations tested. These results add to the growing body of literature indicating that small-molecule inhibitors of virulence genes could be developed to treat infections, as alternatives to antibiotics become increasingly needed.
  
  
  OBJECTIVE
  V. cholerae caused more than 580,000 infections worldwide in 2011 alone (WHO, Wkly. Epidemiol. Rec. 87:289-304, 2012). Cholera is treated with an oral rehydration therapy consisting of water, glucose, and electrolytes. However, as V. cholerae is transmitted via contaminated water, treatment can be difficult for communities whose water source is contaminated. In this study, we address the need for new therapeutic approaches by targeting the production of the main virulence factor, cholera toxin (CT). The high-throughput screen presented here led to the identification of two novel classes of inhibitors of the virulence cascade in V. cholerae, toxtazin A and toxtazins B and B'. We demonstrate that (i) small-molecule inhibitors of virulence gene production can be identified in a high-throughput screen, (ii) targeting virulence gene production is an effective therapeutic strategy, and (iii) small-molecule inhibitors can uncover unknown layers of gene regulation, even in well-studied regulatory cascades.
authors.affiliation: Department of Microbiology and Immunology, University of Michigan, Medical School, Ann Arbor, Michigan, USA.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Anthouard
authors.forename: Victor J
authors.initials: VJ
authors.lastname: DiRita
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors* / Q000096:biosynthesis*; D002771:Cholera / Q000382:microbiology / Q000517:prevention & control; D004353:Drug Evaluation, Preclinical / Q000379:methods; D015870:Gene Expression / Q000187:drug effects*; D057166:High-Throughput Screening Assays; D051379:Mice; D014157:Transcription Factors / Q000037:antagonists & inhibitors* / Q000096:biosynthesis*; D014158:Transcription, Genetic / Q000187:drug effects; D016896:Treatment Outcome; D014734:Vibrio cholerae / Q000187:drug effects* / Q000235:genetics
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D014157:Transcription Factors; C075626:tcpN protein, Vibrio cholerae
references.citation: Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5403-7
references.pmid: 2052618
references.citation: Indian J Med Res. 2011 Feb;133:153-63
references.pmid: 21415489
references.citation: Mol Microbiol. 2001 Jul;41(2):393-407
references.pmid: 11489126
references.citation: Mol Microbiol. 2000 Oct;38(1):67-84
references.pmid: 11029691
references.citation: Nat Chem Biol. 2007 Sep;3(9):541-8
references.pmid: 17710100
references.citation: J Bacteriol. 1988 Jun;170(6):2575-83
references.pmid: 2836362
references.citation: J Bacteriol. 2001 Jan;183(1):178-88
references.pmid: 11114915
references.citation: Science. 2005 Oct 28;310(5748):670-4
references.pmid: 16223984
references.citation: Physiol Rev. 2010 Jul;90(3):859-904
references.pmid: 20664075
references.citation: Mol Microbiol. 2003 Mar;47(5):1459-73
references.pmid: 12603748
references.citation: Mol Microbiol. 1999 Aug;33(4):721-31
references.pmid: 10447882
references.citation: N Engl J Med. 1968 Jul 25;279(4):176-81
references.pmid: 4968807
references.citation: J Bacteriol. 1999 Jul;181(14):4250-6
references.pmid: 10400582
references.citation: ISME J. 2012 Mar;6(3):493-501
references.pmid: 21918575
references.citation: J Clin Microbiol. 1987 Dec;25(12):2314-6
references.pmid: 3429623
references.citation: Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7991-5
references.pmid: 8755590
references.citation: Gene. 1995 Dec 1;166(1):43-8
references.pmid: 8529892
references.citation: Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):810-5
references.pmid: 21187377
references.citation: Clin Infect Dis. 2003 Aug 1;37(3):398-405
references.pmid: 12884165
references.citation: Mol Microbiol. 1997 Jan;23(2):323-31
references.pmid: 9044266
references.citation: Mol Microbiol. 1994 Oct;14(1):17-29
references.pmid: 7830555
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2860-5
references.pmid: 20133655
references.citation: BMC Microbiol. 2010 Jan 06;10:3
references.pmid: 20053280
references.citation: Future Microbiol. 2008 Oct;3(5):563-78
references.pmid: 18811240
references.citation: Infect Immun. 1999 Aug;67(8):3733-9
references.pmid: 10417131
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2372-7
references.pmid: 17283330
references.citation: Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2348-53
references.pmid: 23341592
references.citation: Mol Microbiol. 1998 Feb;27(4):797-805
references.pmid: 9515705
references.citation: Infect Immun. 2005 Sep;73(9):5873-82
references.pmid: 16113306
references.citation: Mol Microbiol. 2010 Sep;77(6):1595-605
references.pmid: 20659293
references.citation: Infect Immun. 2004 Sep;72(9):5478-82
references.pmid: 15322049
references.citation: Microbiol Immunol. 1986;30(11):1075-83
references.pmid: 3543624
references.citation: Proc Natl Acad Sci U S A. 1987 May;84(9):2833-7
references.pmid: 2883655
references.citation: Future Microbiol. 2011 Oct;6(10):1199-208
references.pmid: 22004038
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3028-33
references.pmid: 15699331
references.citation: Mol Microbiol. 2002 Mar;43(6):1471-91
references.pmid: 11952899
references.citation: J Bacteriol. 1999 Apr;181(8):2584-92
references.pmid: 10198025
references.citation: Infect Immun. 2009 Sep;77(9):4111-20
references.pmid: 19564378
references.citation: Gene. 1996 Apr 17;170(1):9-16
references.pmid: 8621096
references.citation: Wkly Epidemiol Rec. 2012 Aug 3;87(31/32):289–304
references.pmid: 22905370
references.citation: Methods Enzymol. 1994;235:517-26
references.pmid: 8057923
references.citation: Indian J Med Res. 2011 Feb;133:232-9
references.pmid: 21415500
references.citation: Mol Microbiol. 2002 Apr;44(2):533-47
references.pmid: 11972789
references.citation: Mol Microbiol. 1999 Feb;31(3):763-71
references.pmid: 10048021
references.citation: J Bacteriol. 2000 Jun;182(11):3228-38
references.pmid: 10809704